International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Iron nanoparticles: The expected impact on our body organs

M Yasser Alsedfy

Electronics and Nano Devices Lab, Faculty of Science, South Valley University, Qena, 83523, Egypt Alexandria University Cancer Research Cluster, Alexandria 21561, Egypt

Article Information

Volume / Issue4 / 2 (2023)
Pages08-14
AccessOpen Access

Publication Timeline

  • Received06 April 2023
  • Accepted23 April 2023

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Nanotechnology is considered as Modern scientific revolution which has a large scale of applications in many fields including the biomedical applications, nanoparticles like carbon nanotubes, and metals/metals oxides nanoparticles as titanium, zinc, iron, silver, gold are used in diagnosis and treatment, studies showed that a lot of these nanoparticles could affect our cells and organs badly due to its toxic effect, so it is important to raise our knowledge about this toxic effect, in this article we will discuss the reported toxic effect of iron/iron oxides nanoparticles as one of the most common used one in many medical applications. 

Keywords

Iron nanoparticlesbodyorgansmedical

References

  1. Reddy LH, R Murthy. Pharmacokinetics and biodistribution studies of doxorubicin loaded poly (butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004. 148(2):161-166. [Google Scholar][Crossref]
  2. Fubini B, M Ghiazza, I Fenoglio, Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology. 2010. 4(4):347-363. [Google Scholar][Crossref]
  3. Verma J, S Lal, CJ Van Noorden. Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma. International journal of nanomedicine. 2014; 9:2863. [Google Scholar][Crossref]
  4. Storz G, JA Imlayt. Oxidative stress. Current opinion in microbiology. 1999; 2(2):188-194. [Google Scholar][Crossref]
  5. Wu H, et al. Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides. Journal of Food and Drug Analysis. 2014; 22(1):86-94. [Google Scholar][Crossref]
  6. Yarjanli Z, et al. Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC neuroscience. 2017; 18(1):51. [Google Scholar][Crossref]
  7. Yu M, et al. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. International journal of molecular sciences. 2012; 13(5):5554-5570. [Google Scholar][Crossref]
  8. Gulbins E, S Dreschers, J Bock. Role of mitochondria in apoptosis. Experimental Physiology. 2003; 88(1):85-90. [Google Scholar][Crossref]
  9. Baratli Y, et al. Age modulates Fe3O4 nanoparticles liver toxicity: dose-dependent decrease in mitochondrial respiratory chain complexes activities and coupling in middle-aged as compared to young rats. BioMed Research International, 2014. [Google Scholar][Crossref]
  10. Mello-Filho AC, R Meneghini. Iron is the intracellular metal involved in the production of DNA damage by oxygen radicals. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 1991; 251(1):109-113. [Google Scholar][Crossref]
  11. Paunovic J, et al. Iron-based nanoparticles and their potential toxicity: Focus on oxidative stress and apoptosis. Chemico-Biological Interactions. 2020; 316:108935. [Google Scholar][Crossref]
  12. Jalili A, S Irani, R Mirfakhraie. Combination of cold atmospheric plasma and iron nanoparticles in breast cancer: Gene expression and apoptosis study. OncoTargets and therapy. 2016; 9:5911. [Google Scholar][Crossref]
  13. Kaluzova M, et al. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles. Oncotarget. 2015; 6(11):8788. [Google Scholar][Crossref]
  14. Thenmozhi T. Functionalization of iron oxide nanoparticles with clove extract to induce apoptosis in MCF-7 breast cancer cells. 3 Biotech. 2020; 10(2):82. [Google Scholar][Crossref]
  15. Hare DJ, et al. A delicate balance: iron metabolism and diseases of the brain. Frontiers in aging neuroscience. 2013; 5:34. [Google Scholar][Crossref]
  16. Petters C, et al. Uptake and metabolism of iron oxide nanoparticles in brain cells. Neurochemical research. 2014; 39(9):1648-1660. [Google Scholar][Crossref]
  17. Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nature Reviews Neuroscience. 2013; 14(8):551-564. [Google Scholar][Crossref]
  18. Umarao P, et al. Neuroprotective potential of super paramagnetic iron oxide nanoparticles along with exposure to electromagnetic field in 6-OHDA rat model of parkinson’s disease. Journal of nanoscience and nanotechnology. 2016; 16(1):261-269. [Google Scholar][Crossref]
  19. Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Advanced drug delivery reviews. 2006; 58(9-10):1030-1060. [Google Scholar][Crossref]
  20. Oberdörster G, E Oberdörster, J Oberdörster. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005; 113:823-839. [Google Scholar][Crossref]
  21. Modrzynska J, et al. In vivo-induced size transformation of cerium oxide nanoparticles in both lung and liver does not affect long-term hepatic accumulation following pulmonary exposure. PloS one, 2018, 13(8). [Google Scholar][Crossref]
  22. Nel A, et al. Toxic potential of materials at the nanolevel science. 2006; 311(5761):622-627. [Google Scholar][Crossref]
  23. Srinivas A, et al. Oxidative stress and inflammatory responses of rat following acute inhalation exposure to iron oxide nanoparticles. Human & experimental toxicology. 2012; 31(11):1113-1131. [Google Scholar][Crossref]
  24. Kim YH, et al. Alveolar epithelial cell injury due to zinc oxide nanoparticle exposure. American journal of respiratory and critical care medicine. 2010; 182(11):1398-1409. [Google Scholar][Crossref]
  25. Morimoto Y, et al. Expression of inflammation-related cytokines following intratracheal instillation of nickel oxide nanoparticles. Nanotoxicology. 2010; 4(2):161-176. [Google Scholar][Crossref]
  26. Capelli A, et al. Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders. American journal of respiratory and critical care medicine. 1997; 155(1):249-253. International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
  27. Sutunkova M, et al. On the contribution of the phagocytosis and the solubilization to the iron oxide nanoparticles retention in and elimination from lungs under long-term inhalation exposure. Toxicology. 2016; 363:19-28. [Google Scholar][Crossref]
  28. Han G, et al. The synthesis and characterization of glutathione-modified superparamagnetic iron oxide nanoparticles and their distribution in rat brains after injection in substantia nigra. Journal of Materials Science: Materials in Medicine. 2019; 30(1):5. [Google Scholar][Crossref]
  29. McCullough BJ, et al. Ferumoxytol in clinical practice: implications for MRI. Journal of Magnetic Resonance Imaging. 2013; 37(6):1476-1479. [Google Scholar][Crossref]
  30. Prina-Mello A, et al. Multiparametric toxicity evaluation of SPIONs by high content screening technique: identification of biocompatible multifunctional nanoparticles for nanomedicine. IEEE transactions on magnetics. 2012; 49(1):377-382. [Google Scholar][Crossref]
  31. Vijayprakash N. Neurobehavioural Toxicity of Iron Oxide Nanoparticles in Mice Possible Mechanisms, 2017. [Google Scholar][Crossref]
  32. Murai J, et al. Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Cancer research. 2012; 72(21):5588-5599. [Google Scholar][Crossref]
  33. Liu PF, et al. Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma. PloS one, 2017, 12(7). [Google Scholar][Crossref]
  34. Wang B, et al. Transport of intranasally instilled fine Fe 2 O 3 particles into the brain: micro-distribution, chemical states, and histopathological observation. Biological trace element research. 2007; 118(3):233-243. [Google Scholar][Crossref]
  35. Wu J, T Ding, J Sun. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology. 2013; 34:243-253. [Google Scholar][Crossref]
  36. Wang B, et al. Neurotoxicity of low-dose repeatedly intranasal instillation of nano-and submicron-sized ferric oxide particles in mice. Journal of nanoparticle research. 2009; 11(1):41-53. [Google Scholar][Crossref]
  37. Fahmy HM, et al. Neurotoxicity of green-synthesized magnetic iron oxide nanoparticles in different brain areas of wistar rats. Neurotoxicology. 2020; 77:80-93. [Google Scholar][Crossref]
  38. Muldoon LL, et al. Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery. 2005; 57(4):785-796. [Google Scholar][Crossref]
  39. Mairuae N, JR Connor, P Cheepsunthorn. Increased cellular iron levels affect matrix metalloproteinase expression and phagocytosis in activated microglia. Neuroscience letters. 2011; 500(1):36-40. [Google Scholar][Crossref]
  40. Zeineh MM, et al. Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiology of aging. 2015; 36(9):2483-2500. [Google Scholar][Crossref]
  41. Sadauskas E, et al. Kupffer cells are central in the removal of nanoparticles from the organism. Particle and fibre toxicology. 2007; 4(1):10. [Google Scholar][Crossref]
  42. Parivar K, et al. Evaluation of iron oxide nanoparticles toxicity on liver cells of BALB/c rats. Iranian Red Crescent Medical Journal, 2016, 18(1). [Google Scholar][Crossref]
  43. Ai J, et al. Nanotoxicology and nanoparticle safety in biomedical designs. International journal of nano medicine. 2011; 6:1117. [Google Scholar][Crossref]
  44. Shakra MESAE, et al. Hepatotoxicity of Bare and Polyethylene Glycol Coated Iron Oxide Nanoparticles and the Protective Role of Virgin Olive Oil in Male Albino Rats. The Egyptian Journal of Hospital Medicine. 2019; 76(2):3607-3617. [Google Scholar][Crossref]
  45. Ng R. Drugs: from discovery to approval. 2015: John Wiley & Sons. [Google Scholar][Crossref]
  46. Wei Y, et al. Iron overload by super paramagnetic iron oxide nanoparticles is a high risk factor in cirrhosis by a systems toxicology assessment. Scientific reports. 2016; 6(1):1-11. [Google Scholar][Crossref]
  47. Predescu AM, et al. Synthesis and characterization of dextran-coated iron oxide nanoparticles. Royal Society open science. 2018; 5(3):171525. [Google Scholar][Crossref]
  48. Easo SL, P Mohanan. Hepatotoxicity evaluation of dextran stabilized iron oxide nanoparticles in Wistar rats. International journal of pharmaceutics. 2016; 509(1-2):28-34. [Google Scholar][Crossref]
  49. Couto D, et al. Biodistribution of polyacrylic acid‐coated iron oxide nanoparticles is associated with proinflammatory activation and liver toxicity. Journal of Applied Toxicology. 2016. 36(10):1321-1331. [Google Scholar][Crossref]
  50. Finco DR. Kidney function, in Clinical biochemistry of domestic animals, 1997, 441-484. [Google Scholar][Crossref]
  51. Mahalakshmi A, GA Kurian. Evaluation of Chemical and Green Synthesized Iron Oxide Nanoparticles’ Associated Renal Toxicity in Different Experimental Models: A Comparative Study. Journal of Cluster Science. 2019; 30(2):343-350. [Google Scholar][Crossref]
  52. Iversen NK, et al. Super paramagnetic iron oxide polyacrylic acid coated γ-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicology and applied pharmacology. 2013; 266(2):276-288. [Google Scholar][Crossref]
  53. Ziv-Polat O, et al. Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials. 2010; 31(4):741-747. [Google Scholar][Crossref]

How to Cite

Alsedfy, M. Y. (2023). Iron nanoparticles: The expected impact on our body organs. International Journal of Medical and All Body Health Research, 4(2), 08-14.

Alsedfy, M Yasser. "Iron nanoparticles: The expected impact on our body organs." International Journal of Medical and All Body Health Research, vol. 4, no. 2, 2023, pp. 08-14.

Alsedfy, M. Y. (2023) 'Iron nanoparticles: The expected impact on our body organs', International Journal of Medical and All Body Health Research, 4(2), pp. 08-14.

Alsedfy MY. Iron nanoparticles: The expected impact on our body organs. International Journal of Medical and All Body Health Research. 2023;4(2):08-14.

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex ResearchGate BASE

A newly published article may take a few days to appear on these services.